Human iPS-derived cardiac cells (Help Therapeutics)

人iPSC来源心肌细胞注射液（艾尔普）

Report date: 2026/05/15 20:01:45

Base Information

Drug NameHuman iPS-derived cardiac cells (Help Therapeutics)
Drug Alias NameHuman Pluripotent Stem Cell-derived Cardiomyocytes (Help Therapeutics)Allogeneic Human Pluripotent Stem Cell-derived Cardiomyocytes therapy (Help Therapeutics)hiPSC-CMs therapy (Help Therapeutics)Human (allogeneic) iPS-cell-derived cardiomyocyte (Help Therapeutics)Human iPS-derived cardiac cells (Help Therapeutics) +[9] 
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Myocardium therapyCell and gene therapy > Cell therapy > Source of cells > iPSC-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHeart FailureCardiomyopathy, DilatedHeart Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHelp Stem Cell Innovations Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChina Resources Sanjiu Medical & Pharmaceutical Co LtdHelp Stem Cell Innovations Co Ltd
Inactive CompaniesN/A
Active IndicationsHeart FailureCardiomyopathy, DilatedHeart Diseases
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A